EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis

Alessia Cottonaro, Saicharan Akula, Berardino Pollio iD, Irene Ricca, Tiziano Martini, Roberto Albiani, Jacopo Agnelli Giacchello, Patrizia Sciancalepore, Roberto Santi, Antonia Follenzi, Simone Merlin iD

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)

DOI: 10.1111/jcmm.71216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 27.05.2026. Verfasst von Alessia Cottonaro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences, Università del Piemonte Orientale, Novara, Italy. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Cytokines, Hemophilia A, Antibodies, Bispecific. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Italia, Grifols, Università degli Studi del Piemonte Orientale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haemophilia A (HA) is an X‐linked bleeding disorder caused by factor VIII (FVIII) deficiency, treated with FVIII infusions or, more recently, Emicizumab subcutaneously. Although Emicizumab is safe and effective, FVIII is still required for severe bleeding, trauma, or surgery, and few studies have compared these prophylactic options in paediatric patients. This study explores the immunological and haematological profiles of paediatric HA patients receiving FVIII or Emicizumab, using haemophilia B patients and healthy controls. Clinical parameters and immune cell populations showed no major differences aside from age‐related variations. However, HA patients displayed higher HLA‐DR expression on CD14 + cells than healthy controls, and Emicizumab‐treated patients showed increased HLA‐DR expression on CD11c + cells compared with FVIII‐treated patients. Plasma cytokines including IL‐12p40, TNF‐α, CCL‐22, IL‐18, and CCL‐4 were elevated in HA, suggesting a dysregulated myeloid compartment in HA. Patient‐derived macrophages exhibited a stronger pro‐inflammatory (M1‐like) polarization after in vitro FVIII stimulation, with increased TNF‐α and reduced TGF‐β gene expression. Stratification by prophylaxis showed that macrophages from FVIII‐treated patients maintained the M1 phenotype, whereas those from Emicizumab‐treated patients showed no clear shift and tended toward an immune‐regulatory profile. These findings highlight distinct myeloid and cytokine signatures associated with different prophylaxis, emphasizing the need for optimized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedCytokinesHemophilia AAntibodies, BispecificFactor VIIIMyeloid CellsHumansChildMaleChild, PreschoolAdolescentMacrophagesInfantFemale

Stichwörter der Autor:innen

HA prophylaxismyeloid cellspaediatric patients

Substanzen

Antibodies, Monoclonal, HumanizedCytokinesAntibodies, BispecificFactor VIIIemicizumab

Autor:innen und Institutionen

  • Health Sciences, Università del Piemonte Orientale, Novara, Italy.
  • Diagnostic Department, A.O. Città Della Salute e Della Scienza, SIMT Immunohematology and Transfusion Medicine Service, Torino, Italy.
  • Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

ORCID-Profile: Berardino Pollio, Simone Merlin

Förderung

  • Roche Italia
  • Grifols
  • Università degli Studi del Piemonte Orientale
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Cottonaro, A., Akula, S., Pollio, B., Ricca, I., Martini, T., Albiani, R., Giacchello, J. A., Sciancalepore, P., Santi, R., Follenzi, A., & Merlin, S. (2026). Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71216

Vancouver

Cottonaro A, Akula S, Pollio B, Ricca I, Martini T, Albiani R, et al. Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71216

BibTeX
@article{Cottonaro2026,
  author = {Cottonaro, Alessia and Akula, Saicharan and Pollio, Berardino and Ricca, Irene and Martini, Tiziano and Albiani, Roberto and Giacchello, Jacopo Agnelli and Sciancalepore, Patrizia and Santi, Roberto and Follenzi, Antonia and Merlin, Simone},
  title = {Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/jcmm.71216}
}
Kostenlos starten →